JRCT ID: jRCTs061180011
Registered date:25/12/2018
Safety and efficacy of TAME for chronic musculoskeletal pain refractory to non-surgical management
Basic Information
Recruitment status | Complete |
---|---|
Health condition(s) or Problem(s) studied | Musculoskeletal chronic pain refractory to non-surgical management (Glenohumeral joint, elbow joint, |
Date of first enrollment | 06/11/2017 |
Target sample size | 20 |
Countries of recruitment | |
Study type | Interventional |
Intervention(s) | Transcatheter arterial micro-embolization using IPM/CS |
Outcome(s)
Primary Outcome | Numerical Rating Scale (NRS) of pain |
---|---|
Secondary Outcome | Feasibility of TAME |
Key inclusion & exclusion criteria
Age minimum | >= 13age old |
---|---|
Age maximum | < 80age old |
Gender | Both |
Include criteria | 1) Previous conservative therapies applied for at least 3 months and persistent moderate-to-severe pain (NRS > 50mm) 2) Elbow, shoulder, hip, knee joint pain. For example, Patients with following diagnosis: adhesive capsulitis, musculoskeletal shoulder pain, tendinopathy and enthesopathy, synovitis and bursitis, mild osteoarthritis (KL<3), infrapatellar fat pad inflammation, and residual or recurrent pain after knee replacement surgery 3) Patients who maintain major organ (bone marrow, heart, liver, lung, kidney) function 4) Below 80 years old in age at the time of the agreement acquisition 20 years old or older 5) Patients who going to hospital follow-up after this treatment enforcement is possible 6) Provided written informed consent to undergo the procedure 7) In the case of a minor, acquisition of the informed consent from the substitute and the ascent from the principal 8) It is possible to re-enroll in the study after the end of the scheduled follow-up period of the previous study. |
Exclude criteria | 1) Adaptation of treating surgically 2) Neoplasm 3) Severe arteriosclerosis 4) Pregnant female, female with the possibility of the pregnancy or nursing female 5).6) Iodine Allergy 7) IPM/CS Allergy 8) Using sodium valproate 9) Patients with the past of hypersensitivity for carbapenem system, penicillin system or cephem antibiotics 10) Severe depression 11) Uncontrollable severe diabetes mellitus 12) Severe renal dysfunction (CCr<10ml/min), patient on hemodialysis 13) Patients who have difficulty in going to hospital follow-up after this treatment enforcement 14) Patients whose abnormal vessels are not recognized in an angiography |
Related Information
Primary Sponsor | Yata Shinsaku |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | UMIN000026094 |
Contact
Public contact | |
Name | Shinsaku Yata |
Address | 36-1 Nishi-cho, Yonago, Tottori,Japan Tottori Japan 683-8504 |
Telephone | +81-859-38-6637 |
yata-s@med.tottori-u.ac.jp | |
Affiliation | Tottori University Hospital |
Scientific contact | |
Name | Shinsaku Yata |
Address | 36-1 Nishi-cho, Yonago, Tottori,Japan Tottori Japan 683-8504 |
Telephone | +81-859-38-6637 |
yata-s@med.tottori-u.ac.jp | |
Affiliation | Tottori University Hospital |